The science refers to the diverse ways of incorporating biotechnology into the treatment of various health issues. One of the most optimistic prognoses on the application of biotechnology in the treatment of the HIV/AIDS is that the disease can be healed by 2020. The future of the HIV treatment has progressed so much further since the disease was first discovered. Thanks to the antiretroviral therapy, the goal of the HIV cure has become much closer to be cured.
One of the most significant obstacles for curing the HIV is the lack of access to care among the different groups of the population. The figure frequently correlates with the social status of the individuals who have the HIV/AIDs and have barriers to accessing the medical care. It is without any doubts that Western countries should focus on the ethical and moral obligations of finding cures for the disease.
Ethically, the cure should be universally applied in the same way in the Western countries and the under-developed countries. As Western nations possess more resources for researching those areas, they have an obligation for the knowledge sharing with other countries who face the low-education literacy in these diseases. In my view, there should not be a difference in approaching these diseases from the perspectives of the different countries. Notably, there must be a general commitment to fighting for the prevention of such diseases from spreading. Whichever country designs the medical treatment for HIV/AIDs, it should definitely take credit for the progress reached. However, finding the cure would be something done for the general good and will serve the overall humanity.
Thus, there is an obligation to proceed with the biotechnological search for curing such diseases as HIV/AIDs around different parts of the world. That way, the treatment will become more sustainable throughout the globe where it is most needed.